TrialTrials2022

A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).

Maryam Shamloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.